Stock screener

NVCR

Conviction 69HealthcareScan · Thu, Sep 24, 2026
Dragonfly doji

NovoCure Ltd (NVCR) closed at $16.20 (-0.31%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 81, -19.0% from its 52-week high, +23.5% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

NVCR$16.20-0.31%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.15M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
NovoCure LtdSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.novocure.com ↗
Price16.20
Change-0.31%
Gap-0.25%
Rel volume1.62×
Avg volume1.07M
Avg $ vol17.8M
SMA 2016.76
SMA 5016.76
SMA 20014.63
Price vs 50-3.35%
Price vs 200+10.72%
MA stackmixed
50/200 cross—
Supertrenddown · 18.12
RSI (14)45
MACD hist-0.03
MACD cross—
Stoch %K / %D38 / 41
ADX (14)15
+DI / −DI18 / 24
RSI divergence—
MACD divergence—
ATR %4.60%
ADR %4.27%
52w high19.99
52w low10.03
From 52w high-18.96%
Above 52w low+61.52%
New 52w highNo
SqueezeOff
Bollinger width19.65%
%B0.33
Donchian pos31.52%
Donchian high18.59
Donchian low15.10
AVWAP (52w high)16.90
vs AVWAP high-4.17%
AVWAP (52w low)14.96
vs AVWAP low+8.28%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d1.62×
Avg vol (14d)1.15M
Avg vol (20d)1.07M
Avg $ vol (20d)17.8M
Market cap1.89B
RS Rating81 / 99
RS 3m (vs SPY)+3.15%
RS 6m (vs SPY)+22.72%
RS line new highNo
Trend template7/8
Technical rank65.8
1 week-3.11%
1 month-8.06%
3 months+7.64%
6 months+39.53%
1 year+24.62%
YTD+23.48%
P/E-13.85
P/B5.58
P/S2.88
P/FCF-24.93
EPS-1.22
Div yield—
ROE-40.29%
ROA-17.13%
Debt/Eq0.58
Current2.89
EV/EBITDA-14.29
Gross margin74.54%
Net margin-20.79%
Rev growth8.28%
EPS growth19.21%
Price target29.50
Target upside82.10%
Analyst ratingBuy
Institutional99.30%
Ent. value1.99B
Revenue183.58M
Net income-15.66M
Gross profit142.48M
Free cash flow-75.68M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out115.82M
Employees1.6K
ListedFri, Oct 2, 2015
Free float105.15M
Float %90.8%
Short interest10.79M
Days to cover7.6d
Short volume51.8%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.30
Last surprise+56.7% beat
Setup gradeB
Conviction69 / 100
Pattern quality—
Tech rank65.8 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NVCR

All disclosures →
No recent disclosed trades by Congress in NVCR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NVCR · open-market 1 sell

InsiderSideShares
Leonard Frank X
Chief Executive Officer · Ordinary Shares · 2026-06-04
Sell34.27K
Ocean Allyson J
Director · Stock Option (Right to Buy) · 2026-06-03
Grant17K
Madden Martin J.
Director · Ordinary Shares · 2026-06-03
Grant11.61K
HILLEMAN JERYL L
Director · Ordinary Shares · 2026-06-03
Grant11.61K
Scannell Timothy J
Director · Stock Option (Right to Buy) · 2026-06-03
Grant17K
LEUNG GABRIEL
Director · Ordinary Shares · 2026-06-03
Grant11.61K
VERNON W ANTHONY
Director · Ordinary Shares · 2026-06-03
Grant11.61K
Stafford Kristin
Director · Ordinary Shares · 2026-06-03
Grant11.61K
VERNON W ANTHONY
Director · Stock Option (Right to Buy) · 2026-06-03
Grant17K
Scannell Timothy J
Director · Ordinary Shares · 2026-06-03
Grant11.61K

SEC filings

EDGAR filings in NVCR · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.